[1]
S. R. M. Anwar, P. H. Hidayati, and P. N. Hamzah, “The Role of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Preventing Cardiovascular Complications in Type 2 Diabetes Mellitus ”, JAFH, vol. 4, no. 3, pp. 15–26, Sep. 2026.